Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"?

Publication ,  Journal Article
Jackson, LR; Daubert, JP; Thomas, KL
Published in: Progress in Cardiovascular Diseases
January 2012

Implantable cardioverter-defibrillator (ICD) therapy improves survival in patients with significant left ventricular systolic dysfunction. Although this lifesaving therapy has many benefits, inappropriate ICD shocks may increase morbidity and mortality. With rates of inappropriate therapy quoted as high as 35% at 3 years after device implantation, numerous strategies have been evaluated to decrease the overall incidence of inappropriate therapy. Changes in programming algorithms, which allow for longer detection windows for rhythm analysis, extended the use of antitachycardia pacing, and improved supraventricular tachycardia discriminators, hold promise for decreasing inappropriate ICD therapy. In this review, we discuss the data summarizing the adverse effects of ICD shocks on outcomes, clinical trial-based programming algorithms to decrease inappropriate shocks, and the expanded role of antitachycardia pacing in ventricular arrhythmia management.

Duke Scholars

Published In

Progress in Cardiovascular Diseases

DOI

EISSN

1873-1740

ISSN

0033-0620

Publication Date

January 2012

Volume

54

Issue

4

Start / End Page

372 / 378

Related Subject Headings

  • Ventricular Dysfunction, Left
  • Tachycardia, Ventricular
  • Shock, Cardiogenic
  • Risk Factors
  • Incidence
  • Humans
  • Forecasting
  • Defibrillators, Implantable
  • Cardiovascular System & Hematology
  • Cardiac Pacing, Artificial
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jackson, L. R., Daubert, J. P., & Thomas, K. L. (2012). Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"? Progress in Cardiovascular Diseases, 54(4), 372–378. https://doi.org/10.1016/j.pcad.2011.11.002
Jackson, Larry R., James P. Daubert, and Kevin L. Thomas. “Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"?Progress in Cardiovascular Diseases 54, no. 4 (January 2012): 372–78. https://doi.org/10.1016/j.pcad.2011.11.002.
Jackson LR, Daubert JP, Thomas KL. Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"? Progress in Cardiovascular Diseases. 2012 Jan;54(4):372–8.
Jackson, Larry R., et al. “Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"?Progress in Cardiovascular Diseases, vol. 54, no. 4, Jan. 2012, pp. 372–78. Epmc, doi:10.1016/j.pcad.2011.11.002.
Jackson LR, Daubert JP, Thomas KL. Expanding the benefits of implantable cardioverter-defibrillator therapy: "is less more"? Progress in Cardiovascular Diseases. 2012 Jan;54(4):372–378.
Journal cover image

Published In

Progress in Cardiovascular Diseases

DOI

EISSN

1873-1740

ISSN

0033-0620

Publication Date

January 2012

Volume

54

Issue

4

Start / End Page

372 / 378

Related Subject Headings

  • Ventricular Dysfunction, Left
  • Tachycardia, Ventricular
  • Shock, Cardiogenic
  • Risk Factors
  • Incidence
  • Humans
  • Forecasting
  • Defibrillators, Implantable
  • Cardiovascular System & Hematology
  • Cardiac Pacing, Artificial